19 January 2026
Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.
19 January 2026
Finance Minister Enoch Godongwana urged a truce in the NHI legal challenges, but political fault lines keep negotiations fragile.
16 January 2026
Finance Minister Godongwana urges the settlement of NHI legal challenges to fast‑track universal healthcare and ease delays from court cases.
16 January 2026
US healthcare spending in 2024 jumped 7.2% to $5.3 trillion, driven by rising insurance enrolment, service use, and administrative costs.
15 January 2026
Aspen Pharmacare business sale boosts investor confidence. A strategic pivot following a turbulent 2025 rebuilds financial flexibility.
15 January 2026
Hospital-acquired infections remain untracked nationally, risking thousands of preventable deaths and silent outbreaks in public hospitals.
15 January 2026
Discovery Health claims will now be covered by the scheme after a processing error led to member outcry and regulatory scrutiny.
15 January 2026
European drug pricing dispute heats up as pharma giants demand higher returns after US price cuts. Tensions are on the rise.
15 January 2026
Discovery Health claims error prompts backlash as 16,000 members face repayments. Critics question the administrative failure.
15 January 2026
GEMS tariff intervention planned as government responds to sharp price hikes affecting public service members and affordability pressures.
14 January 2026
Medscheme Bonitas legal battle over administrator RFPs intensifies as CMS probe and governance concerns cloud SA’s healthcare procurement.
14 January 2026
NHLS cancer test outsourcing cost R116m to clear backlogs, raising sustainability concerns amid tight healthcare budgets.